193 related articles for article (PubMed ID: 22139972)
1. Implications of a positive crossmatch in liver transplantation: a 20-year review.
Ruiz R; Tomiyama K; Campsen J; Goldstein RM; Levy MF; McKenna GJ; Onaca N; Susskind B; Tillery GW; Klintmalm GB
Liver Transpl; 2012 Apr; 18(4):455-60. PubMed ID: 22139972
[TBL] [Abstract][Full Text] [Related]
2. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
3. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?
Joo DJ; Ju MK; Huh KH; Kim MS; Choi GH; Choi JS; Jeon KO; Kim SI
Transplant Proc; 2012 Mar; 44(2):418-20. PubMed ID: 22410032
[TBL] [Abstract][Full Text] [Related]
4. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
[TBL] [Abstract][Full Text] [Related]
5. Pancreas transplantation in crossmatch-positive recipients.
Khwaja K; Wijkstrom M; Gruessner A; Noreen H; Sutherland DE; Humar A; Kandaswamy R; Gruessner RW
Clin Transplant; 2003 Jun; 17(3):242-8. PubMed ID: 12780675
[TBL] [Abstract][Full Text] [Related]
6. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection.
Mattsson J; Nordlander A; Remberger M; Uhlin M; Holgersson J; Ringdén O; Hauzenberger D
Bone Marrow Transplant; 2010 Feb; 45(2):235-8. PubMed ID: 19561647
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
[TBL] [Abstract][Full Text] [Related]
10. Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation.
Noreen HJ; McKinley DM; Gillingham KJ; Matas AJ; Segall M
Transplantation; 2003 Feb; 75(4):501-5. PubMed ID: 12605118
[TBL] [Abstract][Full Text] [Related]
11. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
Opelz G; Döhler B; Süsal C
Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
[TBL] [Abstract][Full Text] [Related]
12. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
[TBL] [Abstract][Full Text] [Related]
13. Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation.
Sugawara Y; Tamura S; Kaneko J; Togashi J; Makuuchi M; Kokudo N
Dig Surg; 2009 Feb; 26(6):482-6. PubMed ID: 20068321
[TBL] [Abstract][Full Text] [Related]
14. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.
Thurairajah PH; Carbone M; Bridgestock H; Thomas P; Hebbar S; Gunson BK; Shah T; Neuberger J
Transplantation; 2013 Apr; 95(7):955-9. PubMed ID: 23442806
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
[TBL] [Abstract][Full Text] [Related]
16. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
Graff RJ; Xiao H; Duffy B; Schnitzler MA; Axelrod D; Lentine KL
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
[TBL] [Abstract][Full Text] [Related]
17. The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.
Graff RJ; Buchanan PM; Dzebisashvili N; Schnitzler MA; Tuttle-Newhall J; Xiao H; Schadde E; Gheorghian A; Lentine KL
Transplant Proc; 2010 Nov; 42(9):3471-4. PubMed ID: 21094799
[TBL] [Abstract][Full Text] [Related]
18. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
20. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
